|
Volumn 27, Issue SUPPL. B, 1991, Pages 61-67
|
Propylaxis, cost and effectiveness of therapy of infections caused by Gram-positive organisms in neutropenic children
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMIKACIN;
CEFTRIAXONE;
TEICOPLANIN;
ANTIBIOTIC AGENT;
GLYCOPEPTIDE;
ACUTE LEUKEMIA;
BACTERIAL INFECTION;
CHILD;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
DRUG SAFETY;
GRAM NEGATIVE BACTERIUM;
GRAM POSITIVE BACTERIUM;
HUMAN;
MAJOR CLINICAL STUDY;
NEUTROPENIA;
PRIORITY JOURNAL;
PROPHYLAXIS;
RANDOMIZED CONTROLLED TRIAL;
ARTICLE;
COST BENEFIT ANALYSIS;
ECONOMICS;
LEUKEMIA;
RANDOMIZATION;
ANTIBIOTICS, COMBINED;
BACTERIAL INFECTIONS;
CEFTRIAXONE;
CHILD;
COST-BENEFIT ANALYSIS;
GLYCOPEPTIDES;
GRAM-POSITIVE BACTERIA;
HUMAN;
LEUKEMIA;
NEUTROPENIA;
RANDOM ALLOCATION;
TEICOPLANIN;
|
EID: 0025852409
PISSN: 03057453
EISSN: None
Source Type: Journal
DOI: 10.1093/jac/27.suppl_b.61 Document Type: Conference Paper |
Times cited : (18)
|
References (0)
|